Why Has Jin Medical International (NASDAQ:ZJYL) Slipped 17.7% Before the Tuesday Open?

Vinay Lochav

10 November 2026 11:43 PM AEDT

Why Has Jin Medical International (NASDAQ:ZJYL) Slipped 17.7% Before the Tuesday Open?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Jin Medical International (NASDAQ:ZJYL) was indicated at USD 3.25 before Tuesday's open on November 10, 2026, 17.7% under a calculated prior close of USD 3.95, after Monday's rise of USD 0.59 or 17.6%.
Based on Monday's close, the company's Market Value stood at USD 30.92 million across 7,827,355 shares, while the pre-market quote implies roughly USD 25.44 million (calculated).
The 52-week range runs from USD 1.53 to USD 5.68, which leaves the pre-market price 42.8% beneath the high and 112.4% above the low, both calculated.
Revenue is USD 19.73 million, total Assets USD 55.8 million, total liabilities USD 25.7 million and a Debt-to-Equity Ratio of 0.85. No pre-market catalyst appeared in published coverage.

Pre-Market Fall of 17.7% for Jin Medical International

Jin Medical International (NASDAQ:ZJYL) was indicated at USD 3.25 ahead of the Tuesday, November 10, 2026 open. Working back from the row gives a prior close of USD 3.95 on Monday, November 9, so the indicated decline is USD 0.70 a share. Monday's session added USD 0.59, or 17.6%, which puts the earlier close near USD 3.36. Because USD 3.25 sits below that level, the pre-market slide wipes out all of Monday's advance. The Business makes and sells wheelchairs, oxygen concentrators and bathing aids from Changzhou, China, and was set up in 2006 as a Subsidiary of Jolly Harmony Enterprises Limited. Average and pre-market Volume figures were not available. Products are sold into several countries, though no split by segment was located. The company reports in USD while operating mainly in China, so currency and regulatory changes can influence its results.

No Catalyst Identified

Published coverage dated November 9 or 10, 2026 shows no catalyst. The latest company items are professional wheelchair Supply for the 12th Jiangsu Provincial Games for Persons with Disabilities and a display of its lightweight rehabilitation range at four global industry expos, both within roughly the past eight days. In general terms, thinly traded small caps often give back sharp one-day gains when no news supports them, and pre-market quotes with few trades can swing widely. A 1-for-20 share consolidation was announced about eight months ago to satisfy Nasdaq's minimum bid rule, and compliance was regained about seven months ago. These steps leave a small share count and a limited float, which magnifies price moves in either direction. Over the past year the shares traded between USD 1.53 and USD 5.68, a 271.2% span from low to high, calculated. First-half fiscal 2026 results were released about three months ago, and no date for the next filing was found.

Valuation, Trading Depth and Risk

Revenue of USD 19.73 million gives a price-to-sales ratio of about 1.57 at Monday's close and about 1.29 at the pre-market quote, both calculated from the market value above. Total assets of USD 55.8 million compare with liabilities of USD 25.7 million, and the debt-to-equity ratio is 0.85. With only 7,827,355 shares on issue, a handful of trades can shift the price, spreads may be wide, and the chance of a Reversal is high. Foreign small caps on Nasdaq can also receive listing notices if the bid price slips below USD 1.00 again. Nothing in these figures points to where the stock heads next. The pre-market price also sits USD 0.11 under the USD 3.36 close that preceded Monday's jump, a calculated gap showing how completely the rally has unwound.

Where Things Stand

Jin Medical International (NASDAQ:ZJYL) is 17.7% lower pre-market, surrendering all of Monday's 17.6% gain, and no catalyst is recorded in published coverage. With a Monday market value of USD 30.92 million, 7,827,355 shares and light pre-market trading, the move looks more like small-cap Volatility than a change in fundamentals.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.